NEW YORK (GenomeWeb) – RPRD Diagnostics announced today that it has signed an agreement to help Children's Minnesota develop a pharmacogenomic testing process.

Under the terms of the deal, Children's Minnesota will begin using RPRD's pharmacogenomic testing platform within its cancer and blood disorder clinic and its neurology/psychology practice. The partners will work together to implement the service. Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.